Aurinia Pharmaceuticals Reports Financial Results for the Three and Twelve Months Ended December 31, 2025 and Provides Update on Recent Business Progress

ROCKVILLE, Md. & EDMONTON, Alberta, February 26, 2026–Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) today announced financial results for the three and twelve months ended December 31, 2025 and provided an update on recent business progress.Read More

What's Trending

Game On: Club and Intramural Sports Fuel Community at Taylor University

Prep talk: Early season look at City Section’s top baseball teams

CNN Sports exclusive: How family, focus and faith fuels Bukayo Saka and Arsenal’s trophy ambitions

Kansas informs trans residents their driver’s licenses become invalid on Thursday

EU top court: Hungary violated EU law by not renewing independent broadcaster’s license

Assisted dying law approved in Jersey

Wary of US investors, Greenland lawmakers push to pass foreign investment screening law

Audit says Harris County Sheriff’s Office not following state law, thousands owed to former inmates

Aurinia Pharmaceuticals Reports Financial Results for the Three and Twelve Months Ended December 31, 2025 and Provides Update on Recent Business Progress

After the WeWork bankruptcy, the coworking industry was looking shaky. Not anymore.

Amazon cloud customers seek lower consulting fees as AI automates work

The ‘Great Wealth Transfer’: A $3 trillion opportunity for Black business owners is on the horizon

Ayotte pitched tax credits for businesses with child care. Here’s how it’s going in the Legislature.

Leave A Reply Cancel Reply

What's Trending

Aurinia Pharmaceuticals Reports Financial Results for the Three and Twelve Months Ended December 31, 2025 and Provides Update on Recent Business Progress

Related Posts

Leave A Reply Cancel Reply

Subscribe to MGSN